The European Medicines Agency approval of 5-aminolaevulinic acid (Ameluz) for the treatment of actinic keratosis of mild to moderate intensity on the face and scalp: Summary of the scientific assessment of the Committee for Medicinal Products for Human Use

Author: Tzogani Kyriaki   Straube Myrjam   Hoppe Ute   Kiely Peter   O’Dea Geraldine   Enzmann Harald   Salmon Patrick   Salmonson Tomas   Pignatti Francesco  

Publisher: Informa Healthcare

ISSN: 1471-1753

Source: Journal of Dermatological Treatment, Vol.25, Iss.5, 2014-10, pp. : 371-374

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content